乙酰胆碱受体与自身免疫疾病

乙酰胆碱受体 (ＡｃｈＲ)是一个配体介导的离子通道蛋白。由 5个同源亚基组成 ,亚基在内质网组成一个环 ,其中 β亚基参与组装序列 ,而未组装的亚基易被降解。肌肉乙酰胆碱受体是神经传导的重要媒介 ,是神经突触处化学信号与电信号相互转换的关键物质。通常肌体内不产生乙酰胆碱受体的抗体 ,但重症肌无力患者由于自身免疫系统紊乱 ,该抗体与乙酰胆碱结合 ,削弱了骨骼肌间的神经传导 ,引起肌无力。因为肌无力症具有典型的自身免疫疾病特点 ,因而对它的研究与自身免疫疾病紧密相关。1 .肌肉乙酰胆碱受体与自体免疫应答反应早在 6 0年代 ,科学…     

秋水仙素对大鼠神经肌肉接头传递的作用

在不均匀牵拉法固定的离体大鼠膈神经膈肌标本上,用秋水仙素探讨了突触后膜的微管在神经肌肉接头乙酰胆碱受体兴奋中的作用。秋水仙素使小终板电位的幅度下降;使串刺激(10Hz,50Hz)诱发的平均终板电位幅度和平均量子含量减少;并使有神经支配的膈肌终板区乙酰胆碱电位幅度降低;但不影响膜电位、小终板电位的频率及终板电位和乙酰胆碱电位的时程。结果表明该药对神经肌肉接头乙酰胆碱受体的兴奋有抑制作用。而其同分异构体光化秋水仙素则无此作用。据此本文提出突触后膜下的微管可能参与神经肌肉接头乙酰胆碱受体的反应过程。     

神经肌肉接头研究世纪回顾

神经肌肉接头作为突触解剖、生理和发育的模型已被研究了一个多世纪。成像技术提供了诸多关于神经肌肉接头的信息,其中一些技术是专为观察该突触的结构和功能而发展起来的。本文回顾了神经肌肉接头研究中几个重要方面的发展史,包括其结构、N型乙酰胆碱受体的分布、突触小泡释放,以及神经肌肉接头的发育。     

烟碱型乙酰胆碱受体及其神经保护作用

新近研究证实,神经元烟碱型乙酰胆碱受体(nAChR)激动后可起到一定的神经保护作用.目前,一些作用于烟碱受体的激动剂已被作为治疗神经退行性疾病如阿尔茨海默病(AD)和帕金森病(PD)的候选药物,但是关于烟碱受体激动后如何发挥神经保护作用及其潜在的分子机制还不清楚,其中有与Ca2+相关的信号转导假说以及神经营养因子等假说.本文就烟碱型乙酰胆碱受体及其神经保护作用的研究进展予以综述.     

昆虫毒蕈碱型乙酰胆碱受体研究进展

毒蕈碱型乙酰胆碱受体（muscarinic acetylcholine receptor,mAchR）是昆虫神经系统中一种十分重要的神经递质受体,属于G蛋白偶联受体超家族,与配体结合后激活G蛋白并通过胞内第二信使产生生物学效应,参与昆虫多种神经生理功能,是农药开发的一个潜在靶标。昆虫毒蕈碱型乙酰胆碱受体的研究,有助于提高昆虫神经生理及行为调节机制等方面的认识,并为以此为靶标的新型杀虫剂研制提供新思路。本文综述了国内外对昆虫毒蕈碱型乙酰胆碱受体的研究概况,并对GenBank中已上传的昆虫mAchR序列进行了分子进化分析,最后对昆虫mAchR研究中存在的问题及前景进行了分析和展望。     

A型肉毒毒素治疗上肢痉挛的应用进展

脑瘫、脑卒中、颅脑外伤、多发性硬化等疾病引起上运动神经元病损均可出现肌肉痉挛,给患者的肢体功能造成不良影响。肉毒毒素是肉毒梭状芽孢杆菌产生的一种毒力极强的嗜神经生物毒素,可阻断神经肌肉接头处的乙酰胆碱的释放,导致肌肉松弛性麻痹。一些临床专家利用肉毒毒素(主要为A型肉毒毒素Botulinum toxin type A,BTX-A)的这种生物活性,来治疗肢体肌肉痉挛,已成为相关医学生物学和临床研究的热点之一。     

纯化眼镜蛇毒蛋白对乙酰胆碱受体通道的阻断作用

在培养的抓蟾胚胎神经和肌肉细胞上用膜片箝技术研究了从中国华南产眼镜蛇毒分离出的神经毒组分对乙酰胆碱受体（ＡＣｈ－Ｒ）通道的影响,发现它在微终板电位和单通道水平上都有明显的阻断作用。完全阻断神经肌肉接点传递的剂量约为２．０μｇ／ｍｌ,对乙酰胆碱受体通道的半阻断量约为０．２３μｇ／ｍｌ。这表明它与α－银环蛇毒有相似功效。     

尼古丁在帕金森病中的神经保护作用

帕金森病(Parkinson’s disease,PD)是常见的中老年神经退行性疾病。研究表明,尼古丁具有抵抗黑质多巴胺神经元损伤的作用,其通过烟碱型乙酰胆碱受体(nicotinic acetylcholine receptor,nAChR)途径与非受体途径抑制帕金森病的发生与发展。本文就尼古丁在帕金森病中的神经保护作用以及保护机制的相关研究进行综述。     

哺乳动物脑烟碱型乙酰胆碱受体的研究进展（综述）

哺乳动物烟碱乙酰胆碱型受体(nAChR)丰要分布于神经肌肉接点、自主神经节及脑组织。神经肌肉接点突触后膜nAChR的功能为十烃季胺(C_(10))所竞争性拮抗,称C_(10)型nAChR。自主神经节突触后膜nAChR的功能为六烃季铵(C_6)所竞争性拮抗,称C_6型nAChR。脑nAChR对激动剂烟碱、对拮抗剂C_6、C_(10)的敏感性等药理学性质不同于C_(10)nAChR,也不完全与C_6nAchR相似,是nAChR的一种新亚型。与CmnAChR的研究相比,脑nAChR的研究明     

神经肌接头上突触前乙酰胆碱自受体及其意义

在神经肌接头上存在着突触前ｎ型和ｍ型乙酰胆碱自受体，两者可能都既介导下在反馈也介导负反馈调节。ｎ型受体与书知的ｎ１和ｎ２受体不同，ｍ型受体与ｍ１型受体类似，突触前乙酰胆碱自受体介导的反馈调节如何影响递质释放尚待阐明。     

重症肌无力患者抗乙酰胆碱受体抗体的测定及意义

用ELISA法对56例重症肌无力(MG)患者治疗前后的血清乙酰胆碱受体(AchR)抗体进行了检测。检测结果为MG患者治疗前后的血清AchR抗体阳性率46.4%。而且发病年龄越大,患者体内AchR抗体阳性率越高。患者患病时间越长体内AchR抗体含量降低。伴发胸腺瘤的患者AchR抗体阳性率明显高于胸腺正常者,全身型MG患者AchR抗体检测阳性率高于眼肌型患者。     

Chemical engineering of a three-fingered toxin with anti-alpha7 neuronal acetylcholine receptor activity

Though it possesses four disulfide bonds the three-fingered fold is amenable to chemical synthesis, using a Fmoc-based method. Thus, we synthesized a three-fingered curaremimetic toxin from snake with high yield and showed that the synthetic and native toxins have the same structural and biological properties. Both were characterized by the same 2D NMR spectra, identical high binding affinity (K(d) = 22 +/- 5 pM) for the muscular acetylcholine receptor (AChR) and identical low affinity (K(d) = 2.0 +/- 0.4 microM) for alpha7 neuronal AchR. Then, we engineered an additional loop cyclized by a fifth disulfide bond at the tip of the central finger. This loop is normally present in longer snake toxins that bind with high affinity (K(d) = 1-5 nM) to alpha7 neuronal AchR. Not only did the chimera toxin still bind with the same high affinity to the muscular AchR but also it displayed a 20-fold higher affinity (K(d) = 100 nM) for the neuronal alpha7 AchR, as compared with the parental short-chain toxin. This result demonstrates that the engineered loop contributes, at least in part, to the high affinity of long-chain toxins for alpha7 neuronal receptors. That three-fingered proteins with four or five disulfide bonds are amenable to chemical synthesis opens new perspectives for engineering new activities on this fold.     

Novel immunotoxin: a fusion protein consisting of gelonin and an acetylcholine receptor fragment as a potential immunotherapeutic agent for the treatment of Myasthenia gravis

In continuation of our attempts for antigen-specific suppression of the immune system [I.L. Urbatsch, R.K.M. Sterz, K. Peper, W.E. Trommer, Eur. J. Immunol. 23(1993) 776-779] a novel fusion protein composed of amino acids 4-181 of the extracellular domain of the alpha-subunit of the human muscle acetylcholine receptor and the plant toxin gelonin was expressed in Escherichia coli. The fusion protein formed inclusion bodies but could be solubilized in the presence of guanidinium hydrochloride. After a simple two step purification and refolding procedure, it exhibited a native structure at least in the main immunogenic region as shown by antibodies recognizing a conformational epitope. Half maximal inhibition of translation was achieved at 46 ng/ml as compared to 4.6 ng/ml for native and 2.4 for recombinant gelonin. Its use as therapeutic agent for the treatment of Myasthenia gravis was investigated in an animal model. Female Lewis rats were immunized with complete acetylcholine receptor from the electric ray Torpedo californica and developed thereafter experimental autoimmune M. gravis. Quantitative assessment of the disease was achieved by repetitive stimulation of the Nervus tibialis. Rats showed no symptoms of M. gravis, neither visually nor electrophysiologically after treatment with the fusion protein as determined one and seven weeks after the second application. This approach may also be useful for the therapy of further autoimmune diseases by substituting other autoantigens for the AchR fragment in the fusion protein.     

(1-Pyrene)sulfonyl azide: a fluorescent probe for measuring the transmembrane topology of acetylcholine receptor subunits

(1-Pyrene)sulfonyl azide (PySA), a fluorescent, lipophilic photolabel, was used as a probe for the transmembrane topology of the acetylcholine receptor (AchR) subunits. Photolabeling of native, alkaline-extracted, and reconstituted AchR membrane preparations resulted in the labeling of all the AchR subunits. However the reconstituted AchR membrane preparations incorporated twice as much PySA into each mole of the AchR complex. Photolabeling of all subunits of the AchR does not appear to alter the agonist concentration response of AchR-mediated cation translocation.     

Asynchronous assembly of the acetylcholine receptor and of the 43-kD nu1 protein in the postsynaptic membrane of developing Torpedo marmorata electrocyte

The assembly of the nicotinic acetylcholine receptor (AchR) and the 43-kD protein (v1), the two major components of the post synaptic membrane of the electromotor synapse, was followed in Torpedo marmorata electrocyte during embryonic development by immunocytochemical methods. At the first developmental stage investigated (45-mm embryos), accumulation of AchR at the ventral pole of the newly formed electrocyte was observed within columns before innervation could be detected. No concomitant accumulation of 43-kD immunoreactivity in AchR-rich membrane domains was observed at this stage, but a transient asymmetric distribution of the extracellular protein, laminin, which paralleled that of the AchR, was noticed. At the subsequent stage studied (80-mm embryos), codistribution of the two proteins was noticed on the ventral face of the cell. Intracellular pools of AchR and 43-kD protein were followed at the EM level in 80-mm electrocytes. AchR immunoreactivity was detected within membrane compartments, which include the perinuclear cisternae of the endoplasmic reticulum and the plasma membrane. On the other hand, 43-kD immunoreactivity was not found associated with the AchR in the intracellular compartments of the cell, but codistributed with the AchR at the level of the plasma membrane. The data reported in this study suggest that AchR clustering in vivo is not initially determined by the association of the AchR with the 43-kD protein, but rather relies on AchR interaction with extracellular components, for instance from the basement membrane, laid down in the tissue before the entry of the electromotor nerve endings.     

Formation of acetylcholine receptor clusters in mammalian sternohyoid muscle regenerating in the absence of nerves

When the sternohyoid muscle from the rat is grafted, the original muscle fibers, including the membranes at the neuromuscular junction, degenerate irreversibly. New muscle fibers regenerate inside of the basal laminae remaining from the original muscle fibers. In this study rhodamine-alpha-bungarotoxin and electron microscopy have been used to demonstrate that acetylcholine receptor (AchR) clusters and synaptic folds are restored to the regenerating myotubes even when innervation to the grafts is prevented. The AchR clusters and synaptic folds colocalized with acetylcholinesterase that persisted at the original synaptic basal lamina. The AchR clusters were not restored if the original innervation band was removed from the muscle at the time of grafting. Lengths of the AchR clusters were measured in animals ranging in weight from 50 to 700 g. The lengths of clusters in the grafts were proportional to the lengths of those in the preoperative controls, suggesting that quantitative morphogenetic information persists through the period of degeneration and regeneration. However, the distribution of the AchRs within the clusters differed slightly from controls. Extrajunctional AchR clusters were present initially, but later disappeared. The sizes of these clusters were unrelated to the sizes of the junctional AchR clusters. This study demonstrates that morphogenetic cues persist within the region of the original motor and plate, possibly associated with the synaptic basal lamina.     

Photoaffinity labeling of the Torpedo californica nicotinic acetylcholine receptor with an aryl azide derivative of phosphatidylserine

A photoactivatable analogue of phosphatidylserine, 125I-labeled 4-azidosalicylic acid-phosphatidylserine (125I ASA-PS), was used to label both native acetylcholine receptor (AchR)-rich membranes from Torpedo californica and AchR membranes affinity purified from Torpedo reconstituted into asolectin (a crude soybean lipid extract) vesicles. The radioiodinated arylazido group attaches directly to the phospholipid head group and thus probes for regions of the AchR structure in contact with the negatively charged head group of phosphatidylserine. All four subunits of the AchR incorporated the label, with the alpha subunit incorporating approximately twice as much as each of the other subunits on a per mole basis. The regions of the AchR alpha subunit that incorporated 125I ASA-PS were mapped by Staphylococcus aureus V8 protease digestion. The majority of label incorporated into fragments representing a more complete digestion of the alpha subunit was localized to 11.7- and 10.1-kDa V8 cleavage fragments, both beginning at Asn-339 and of sufficient length to contain the hydrophobic regions M1, M2, and M3 was also significantly labeled. In contrast, V8 cleavage fragments representing roughly a third of the amino-terminal portion of the alpha subunit incorporated little or no detectable amount of probe.     

Myasthenia Gravis: Analysis of Serum Autoantibody Reactivities to 1827 Potential Human Autoantigens by Protein Macroarrays

Background

Myasthenia gravis is a disorder of neuromuscular transmission associated with autoantibodies against the nicotinic acetylcholine receptor. We have previously developed a customized protein macroarray comprising 1827 potential human autoantigens, which permitted to discriminate sera of patients with different cancers from sera of healthy controls, but has not yet been evaluated in antibody-mediated autoimmune diseases.

Objective

To determine whether autoantibody signatures obtained by protein macroarray separate sera of patients with myasthenia gravis from healthy controls.

Methods

Sera of patients with acetylcholine receptor antibody-positive myasthenia gravis (n = 25) and healthy controls (n = 32) were analyzed by protein macroarrays comprising 1827 peptide clones.

Results

Autoantibody signatures did not separate patients with myasthenia gravis from controls with sufficient sensitivity, specificity, and accuracy. Intensity values of one antigen (poly A binding protein cytoplasmic 1, p = 0.0045) were higher in patients with myasthenia gravis, but the relevance of this and two further antigens, 40S ribosomal protein S13 (20.8% vs. 0%, p = 0.011) and proteasome subunit alpha type 1 (25% vs. 3.1%, p = 0.035), which were detected more frequently by myasthenia gravis than by control sera, currently remains uncertain.

Conclusion

Seroreactivity profiles of patients with myasthenia gravis detected by a customized protein macroarray did not allow discrimination from healthy controls, compatible with the notion that the autoantibody response in myasthenia gravis is highly focussed against the acetylcholine receptor.     

Consequences of alkaline treatment for the ultrastructure of the acetylcholine-receptor-rich membranes from Torpedo marmorata electric organ

After fixation with glutaraldehyde and impregnation with tannic acid, the membrane that underlies the nerve terminals in Torpedo marmorata electroplaque presents a typical asymmetric triple-layered structure with an unusual thickness; in addition, it is coated with electron- dense material on its inner, cytoplasmic face. Filamentous structures are frequently found attached to these "subsynaptic densities." The organization of the subsynaptic membrane is partly preserved after homogenization of the electric organ and purification of acetylcholine- receptor (AchR)-rich membrane fragments. In vitro treatment at pH 11 and 4 degrees C of these AchR-rich membranes releases an extrinsic protein of 43,000 mol wt and at the same time causes the complete disappearance of the cytoplasmic condensations. Freeze-etching of native membrane fragments discloses remnants of the ribbonlike organization of the AchR rosettes. This organization disappears ater alkaline treatment and is replaced by a network which is not observed after rapid freezing and, therefore, most likely results from the lateral redistribution of the AchR rosettes during condition of slow freezing. A dispersion of the AchR rosettes in the plane of the membrane also occurs after fusion of the pH 11-treated fragments with phospholipid vesicles. These results are interpreted in terms of a structural stabilization and immobilization of the AchR by the 43,000- Mr protein binding to the inner face of the subsynaptic membrane.     

Induced Formation and Maturation of Acetylcholine Receptor Clusters in a Defined 3D Bio-Artificial Muscle

Dysfunction of the neuromuscular junction is involved in a wide range of muscular diseases. The development of neuromuscular junction through which skeletal muscle is innervated requires the functional modulation of acetylcholine receptor (AchR) clustering on myofibers. However, studies on AchR clustering in vitro are mostly done on monolayer muscle cell culture, which lacks a three-dimensional (3D) structure, a prominent limitation of the two-dimensional (2D) system. To enable a better understanding on the structure–function correlation underlying skeletal muscle innervation, a muscle system with a well-defined geometry mimicking the in vivo muscular setting is needed. Here, we report a 3D bio-artificial muscle (BAM) bioengineered from green fluorescent protein-transduced C3H murine myoblasts as a novel in vitro tissue-based model for muscle innervation studies. Our cell biological and molecular analysis showed that this BAM is structurally similar to in vivo muscle tissue and can reach the perinatal differentiation stage, higher than does 2D culture. Effective clustering and morphological maturation of AchRs on BAMs induced by agrin and laminin indicate the functional activity and plasticity of this BAM system toward innervation. Taken together, our results show that the BAM provides a favorable 3D environment that at least partially recapitulates real physiological skeletal muscle with regard to innervation. With a convenience of fabrication and manipulation, this 3D in vitro system offers a novel model for studying mechanisms underlying skeletal muscle innervation and testing therapeutic strategies for relevant nervous and muscular diseases.